|
|
Article: Renagel Study in New Dialysis Patients Published in Kidney International.
- Article from:
- PR Newswire
- Article date:
- September 29, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Support Early Treatment with Renagel
CAMBRIDGE, Mass., Sept. 29 /PRNewswire-FirstCall/ -- Genzyme Corporation announced today that results from the Renagel in New Dialysis (RIND) study have been published in the October issue of Kidney International. Investigators in the RIND study compared the effects of Renagel(R) (sevelamer hydrochloride) with calcium-based phosphate binders for a period of 18 months in patients who were new to hemodialysis.
According to the study, each treatment group achieved the target levels for phosphorus and calcium-phosphorus product outlined in the 2003 National Kidney Foundation's Kidney Disease Outcomes Quality ...